Zoom Logo

AMSPDC Research Committee Webinar Series - February 2022 - Shared screen with speaker view
AMSPDC info@amspdc.org
06:16
Welcome everyone! Please keep your line muted unless speaking.
Lisa Satlin
17:24
Please raise your hands or post questions to the panelists in the chat thread! Andrew will then call on you.
Nicholas Puoplo
39:12
Thank you all for your valuable input. I was curious for input on your thoughts of MDs without PhDs competing for funding, publications, etc... Of course clinical time interrupts research time so challenges exist vs a 100% dedicated scientist team. Thanks!
Jonathan Witonsky
44:11
Thank you, Bereketeab, for specifying why you pursued K99/R00 vs other mechanisms. Could you clarify why this was better option compared to e.g., K08? Also, for others, why did you, respectively, target K08 and K23 (e.g., vs K99…)? Thanks!
Nicholas Puoplo
45:37
thanks!
Jonathan Witonsky
52:06
Very helpful. Thank you! To what extent did you “shop around” speaking to different IC POs?
Matthew Kan
54:18
10-100 i think?
Matthew Kan
54:23
it’s the 1-10 score x 10
Matthew Kan
54:55
meaning Matt had an incredible best possible score
Conor Gruber
55:17
Have to dip out early, but thank you — all very helpful !
Andrew Cox
59:09
https://reporter.nih.gov/
Matthew Vogt
59:43
Secret to a 10: get comments on your first submission, do whatever the comments request that you do and praise them as wonderful ideas, and resubmit to the same reviewers. Then those reviewers think “wow, this person really gets it!”
Tuba Kockar Kizilirmak
01:07:11
Thank you very much this meeting. It was very helpful.
Elizabeth Beals
01:07:30
Thank you!